BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35421368)

  • 1. Knockdown of TRIM65 suppressed the proliferation and invasiveness of gastric cancer cells by restricting the ubiquitin degradation of PPM1A.
    Liu C; Sun W; Yang K; Xia B
    Exp Cell Res; 2022 Jul; 416(2):113154. PubMed ID: 35421368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
    Wang XL; Shi WP; Shi HC; Lu SC; Wang K; Sun C; He JS; Jin WG; Lv XX; Zou H; Shu YS
    Oncotarget; 2016 Dec; 7(49):81527-81540. PubMed ID: 27829229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
    Wang XL; Shi WP; Shi HC; Lu SC; Wang K; Sun C; He JS; Jin WG; Lv XX; Zou H; Shu YS
    Oncotarget; 2024 May; 15():312. PubMed ID: 38753318
    [No Abstract]   [Full Text] [Related]  

  • 4. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Zhang CZ
    J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6.
    Wu YT; Ma SY; Sun WQ; Shen WW; Zhu HT; Zhang Q; Chen HF
    J Clin Endocrinol Metab; 2021 Jan; 106(2):526-538. PubMed ID: 33146694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
    Wei WS; Chen X; Guo LY; Li XD; Deng MH; Yuan GJ; He LY; Li YH; Zhang ZL; Jiang LJ; Chen RX; Ma XD; Wei S; Ma NF; Liu ZW; Luo JH; Zhou FJ; Xie D
    Cancer Lett; 2018 Oct; 435():10-22. PubMed ID: 30075204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM65 Promotes Malignant Cell Behaviors in Triple-Negative Breast Cancer by Impairing the Stability of LATS1 Protein.
    Lu Y; Xiao Y; Yang J; Su H; Zhang X; Su F; Tian B; Zhao D; Ling X; Zhang T
    Oxid Med Cell Longev; 2022; 2022():4374978. PubMed ID: 36035221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LINC01857 promotes growth, migration, and invasion of glioma by modulating miR-1281/TRIM65 axis.
    Hu G; Liu N; Wang H; Wang Y; Guo Z
    J Cell Physiol; 2019 Dec; 234(12):22009-22016. PubMed ID: 31049960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X; Chen Y; Shen Y; Tantai J
    Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC00963 promotes colorectal cancer cell proliferation and metastasis by regulating miR‑1281 and TRIM65.
    Lv H; Zhou D; Liu G
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3.
    Zhang Q; Li Y; Zhu Q; Xie T; Xiao Y; Zhang F; Li N; Deng K; Xin H; Huang X
    Cell Death Dis; 2024 May; 15(5):355. PubMed ID: 38777825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM65 E3 ligase targets VCAM-1 degradation to limit LPS-induced lung inflammation.
    Li Y; Huang X; Guo F; Lei T; Li S; Monaghan-Nichols P; Jiang Z; Xin HB; Fu M
    J Mol Cell Biol; 2020 Apr; 12(3):190-201. PubMed ID: 31310649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer.
    Wang C; Xu J; Fu H; Zhang Y; Zhang X; Yang D; Zhu Z; Wei Z; Hu Z; Yan R; Cai Q
    J Cell Mol Med; 2018 Oct; 22(10):5020-5028. PubMed ID: 30079558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM65 negatively regulates p53 through ubiquitination.
    Li Y; Ma C; Zhou T; Liu Y; Sun L; Yu Z
    Biochem Biophys Res Commun; 2016 Apr; 473(1):278-282. PubMed ID: 27012201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis.
    Wang F; Wang H; Sun L; Niu C; Xu J
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C392-C401. PubMed ID: 32348176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation.
    Chen D; Li Y; Zhang X; Wu H; Wang Q; Cai J; Cui Y; Liu H; Lan P; Wang J; Yang Z; Wang L
    Oncogene; 2019 Sep; 38(37):6429-6444. PubMed ID: 31332286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM65 is a potential oncogenic protein via ERK1/2 on Jurkat and Raji cells: A therapeutic target in human lymphoma malignancies.
    Wang J; Liang X; Yu T; Xu YL; Xu LH; Zhang XJ; Ma J; Wang YR; He SL
    Cell Biol Int; 2018 Nov; 42(11):1503-1510. PubMed ID: 30039885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3.
    Tang T; Li P; Zhou X; Wang R; Fan X; Yang M; Qi K
    Front Immunol; 2021; 12():741839. PubMed ID: 34512673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
    Guo C; Wang H; Jiang H; Qiao L; Wang X
    Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.